 |
 |
 |
||||||
|
||||||||
 |
||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
A number of legal actions have been brought against GlaxoSmithKline, the manufacturer of prescription drug Avandia (rosiglitazone maleate), to recover for congestive heart failure or liver damage allegedly caused by the drug. If you believe you have been experienced any of the above-mentioned injuries while taking Avandia, Contact us today for a free consultation. On May 21, 2007, the FDA issued a safety alert regarding Avandia. In the letter published on its web site, it stated that, "safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia." However, the FDA also stated that other ongoing and unpublished studies showed a preliminary contradiction with the initial data. Regardless, the risk of cardiovascular events and the serious consequences that result from such heart problems led the FDA to report this problem and to issue this warning. Statistically, studies showed an increase risk of heart problems by a factor of 30 - 40% for those patients who were taking Avandia.
|
 |
© 2005 - 2010 Capretz & Associates. All rights reserved. |